About
IndiTreat, developed by 2cureX, offers CE IVD-marked functional drug sensitivity tests using patient-derived organoids to predict metastatic colorectal cancer patients' responses and resistance to chemotherapy regimens.
Explore IndiTreat (2cureX)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.